SGK-1 Signalling Pathway is a Key Factor in Cell Survival in Ischemic Injury
- PMID: 37904552
- DOI: 10.2174/0113894501239948231013072901
SGK-1 Signalling Pathway is a Key Factor in Cell Survival in Ischemic Injury
Abstract
Serum and glucocorticoid-regulated kinases (SGK) are serine/threonine kinases that belong to AGC. The SGK-1, which responds to stress, controls a range of ion channels, cell growth, transcription factors, membrane transporters, cellular enzymes, cell survival, proliferation and death. Its expression is highly controlled by various factors such as hyperosmotic or isotonic oxidative stress, cell shrinkage, radiation, high blood sugar, neuronal injury, DNA damage, mechanical stress, thermal shock, excitement, dehydration and ischemia. The structural and functional deterioration that arises after a period of ischemia when blood flow is restored is referred to as ischemia/ reperfusion injury (I/R). The current review discusses the structure, expression, function and degradation of SGK-1 with special emphasis on the various ischemic injuries in different organs such as renal, myocardial, cerebral, intestinal and lungs. Furthermore, this review highlights the various therapeutic agents that activate the SGK-1 pathway and slow down the progression of I/R injuries.
Keywords: Ischemia-reperfusion; SGK-1; apoptosis; cell survival.; inflammation; oxidative stress.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Gender differences in serum and glucocorticoid regulated kinase-1 (SGK-1) expression during renal ischemia/reperfusion injury.Cell Physiol Biochem. 2011;27(6):727-38. doi: 10.1159/000330081. Epub 2011 Jun 17. Cell Physiol Biochem. 2011. PMID: 21691090
-
SGK-1 regulates inflammation and cell death in the ischemic-reperfused heart: pressure-related effects.Am J Hypertens. 2014 Jun;27(6):846-56. doi: 10.1093/ajh/hpt269. Epub 2014 Jan 15. Am J Hypertens. 2014. PMID: 24429675
-
Dexamethasone protects from renal ischemia/reperfusion injury: a possible association with SGK-1.Acta Physiol Hung. 2013 Jun;100(2):173-85. doi: 10.1556/APhysiol.100.2013.001. Acta Physiol Hung. 2013. PMID: 23524182
-
Serum Glucocorticoid-Regulated Kinase-1 in Ischemia-Reperfusion Injury: Blessing or Curse.J Pharmacol Exp Ther. 2023 Dec;387(3):277-287. doi: 10.1124/jpet.123.001846. Epub 2023 Sep 28. J Pharmacol Exp Ther. 2023. PMID: 37770199 Review.
-
Second AKT: the rise of SGK in cancer signalling.Growth Factors. 2010 Dec;28(6):394-408. doi: 10.3109/08977194.2010.518616. Epub 2010 Oct 5. Growth Factors. 2010. PMID: 20919962 Review.
Cited by
-
Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain.Exp Neurol. 2024 Dec;382:114973. doi: 10.1016/j.expneurol.2024.114973. Epub 2024 Sep 24. Exp Neurol. 2024. PMID: 39326820 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources